LivaNova (NASDAQ:LIVN) Reaches New 1-Year High – What’s Next?

LivaNova PLC (NASDAQ:LIVN) shares hit a new 52-week high on Thursday . The company traded as high as $65.57 and last traded at $64.0550, with a volume of 41233 shares changing hands. The stock had previously closed at $64.06.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on LIVN shares. Barclays raised their target price on LivaNova from $55.00 to $58.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 21st. The Goldman Sachs Group set a $55.00 price target on shares of LivaNova and gave the stock a “neutral” rating in a research report on Wednesday, October 1st. Mizuho upped their price objective on shares of LivaNova from $65.00 to $70.00 and gave the company an “outperform” rating in a report on Thursday, November 13th. Robert W. Baird increased their price objective on shares of LivaNova from $63.00 to $70.00 and gave the stock an “outperform” rating in a research note on Thursday, November 13th. Finally, Needham & Company LLC restated a “buy” rating and set a $64.00 target price on shares of LivaNova in a research report on Wednesday, September 3rd. Five research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $62.43.

LivaNova Price Performance

The stock has a market capitalization of $3.47 billion, a PE ratio of -15.88 and a beta of 1.02. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.33 and a quick ratio of 1.12. The stock’s fifty day moving average is $55.80 and its 200-day moving average is $51.30.

Institutional Trading of LivaNova

Several institutional investors have recently bought and sold shares of LIVN. Artisan Partners Limited Partnership grew its holdings in LivaNova by 94.5% in the 3rd quarter. Artisan Partners Limited Partnership now owns 2,427,045 shares of the company’s stock valued at $127,129,000 after buying an additional 1,179,436 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of LivaNova by 83.5% in the third quarter. Wellington Management Group LLP now owns 2,345,516 shares of the company’s stock valued at $122,858,000 after purchasing an additional 1,067,349 shares during the period. Invesco Ltd. increased its position in LivaNova by 714.7% during the second quarter. Invesco Ltd. now owns 1,028,713 shares of the company’s stock worth $46,313,000 after purchasing an additional 902,447 shares during the last quarter. AQR Capital Management LLC raised its stake in LivaNova by 111.7% during the first quarter. AQR Capital Management LLC now owns 1,571,295 shares of the company’s stock worth $60,809,000 after purchasing an additional 829,115 shares during the period. Finally, Scopia Capital Management LP purchased a new position in LivaNova during the second quarter worth about $36,657,000. 97.64% of the stock is owned by institutional investors and hedge funds.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.